Clomiphene Citrate Tablets IP 25 MG - LOFERT 25 Tablets

LOFERT 25 Tablets – Triple Action for Stronger Reproductive Potential.

LOFERT 25 Tablets – Clomiphene Citrate Tablets IP 25 mg combine ovulation induction, metabolic support, and antioxidant protection to improve reproductive outcomes in women with PCOS and related infertility conditions.
Clomiphene Citrate Tablets IP 25 mg offer an integrated approach to female fertility enhancement by addressing the three key barriers to conception in PCOS and related infertility—ovulation dysfunction, insulin resistance, and oxidative stress. Clomiphene Citrate, a selective estrogen receptor modulator (SERM), induces ovulation; N-Acetylcysteine optimizes metabolic and ovarian responsiveness; and Astaxanthin, a potent antioxidant, boosts reproductive cell health and embryo quality.

Key Benefits of Clomiphene Citrate Tablets IP 25 mg – LOFERT 25 Tablets
✅ Clomiphene for Effective Ovulation Induction – Stimulates the release of FSH and LH to promote ovulation, particularly beneficial in anovulatory infertility linked to PCOS.
✅ NAC for Metabolic & Ovarian Support – Enhances insulin sensitivity, reduces oxidative stress, and improves follicular development to restore ovulatory function in PCOS patients.
✅ Astaxanthin for Antioxidant Protection – Safeguards ovarian cells from oxidative damage, supports healthy embryo development, and improves implantation potential.

Recommended by Specialists:
👨‍⚕️ Gynecologists & Obstetricians – for managing PCOS-related infertility, ovulation induction, and assisted reproductive protocols.
👨‍⚕️ Reproductive Endocrinologists – for advanced fertility treatments and hormonal imbalance management.

Indications:
✅ PCOS-Related Anovulatory Infertility
✅ Clomiphene-Resistant Ovulatory Disorders
✅ Poor Oocyte Quality & Oxidative Stress
✅ Hormonal Imbalance-Associated Subfertility
✅ Ovulation Induction in Assisted Reproductive Protocols